Dr. Scott Tiplitsky, MD
1660 Feehanville DR Ste 200, Mount Prospect, IL 60056 • +1-216-555-3780
Medical Education: Accredited U.S. Medical School (Class of 1997)
What This Doctor Actually Performs: CMS Medicare Utilization & Mount Prospect Percentiles
NPI #1619117298 • CBSA Regional • Urology
Dr. Scott Tiplitsky, MD (NPI #1619117298) practices Urology in Mount Prospect, IL (60056) with sub-specialty concentration in 75 Active CMS HCPCS Codes, recording 6,547 annual CMS services across 852 distinct beneficiaries—placing this practice as a mid-cohort balanced caseload (42.86th Mount Prospect percentile) (-0.16σ vs IL state mean, 58.33th statewide percentile).
Procedural volume for Dr. Tiplitsky is led by HCPCS 99214 (Established Urologic, BPH & Androgen Evaluation — 1392 annual services, $99–$136 GPCI cash estimate), followed by CPT 51798 (Ultrasound Measurement of Post-Void Residual Urine Capacity, 1044/yr) and CPT 52000 (Diagnostic Cystourethroscopy Lower Urinary Tract Inspection, 657/yr).
Self-pay new patient consultations with Dr. Tiplitsky (CPT 99204 GPCI-adjusted benchmark) estimate around $218.00 (community reported average: $218.00) with hybrid in-clinic and telehealth video consults, 13-minute average reception wait, and a 4.57/5 modern protocol openness score across 11 patient logs.
Patients evaluating Dr. Scott Tiplitsky in ZIP 60056 note 29 years of post-doctoral tenure (null, 1997) alongside 7.7 annual CMS procedures per patient.
Compared against Mount Prospect, IL Urology peers
6,547 annual services across 852 beneficiaries
Standard deviations from IL Urology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Established Urologic, BPH & Androgen Evaluation | 1,392 | 42.86th | $99 – $136 |
| 51798 | Ultrasound Measurement of Post-Void Residual Urine Capacity | 1,044 | 42.86th | $41 – $57 |
| 52000 | Diagnostic Cystourethroscopy Lower Urinary Tract Inspection | 657 | 38.86th | $203 – $278 |
| 51741 | Complex Electronic Uroflowmetry Stream Calibration | 464 | 37.86th | $56 – $77 |
| 99204 | New Patient Urologic & Prostate Diagnostic Consultation | 309 | 46.86th | $140 – $191 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (75 HCPCS billing breadth) | 2,680 | 42.86th | $89 – $129 |
Are you Dr. Scott Tiplitsky? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Mount Prospect, IL:
<a href="https://dotmd.com/doctors/scott-tiplitsky-md-mount-prospect-il-1619117298" title="Dr. Scott Tiplitsky, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1619117298.svg" alt="Dr. Scott Tiplitsky Urology Badge" width="280" height="72" /></a>
Dr. Scott Tiplitsky, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Tiplitsky National Provider Identifier | NPI #1619117298 (MD) | CMS NPPES Registry (60056) |
| Dr. Tiplitsky Mount Prospect CMS Volume Rank | 42.86th Pct (6,547 CMS svcs; Z -0.160σ) | CMS Medicare Part B (IL Urology) |
| Fair Cash-Pay New-Patient Benchmark | $218.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Mount Prospect, IL) |
| Waiting-Room Wait Time & Cash Friendliness | $218.00 avg paid • 13 min lobby wait | 11 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.59/5 Listening • 4.57/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Scott Tiplitsky
Other High-Volume Urology Specialists in Mount Prospect, IL
Ranked strictly by CMS Medicare volumeDr. Tiplitsky Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Mount Prospect, IL.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Scott Tiplitsky community threads and patient logs by age, biological sex, dosage, and treatment duration.